We are monitoring the impact of COVID-19 on High Potency API (HPAPI) Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 8655
Share on
Share on

High Potency API / HPAPI Market Report - Segmented By Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2026

Pulished: April, 2021
ID: 8655
Pages: 170

Global High Potency API / HPAPI Market Size & Growth (2021–2026)

The global HPAPI market is expected to reach USD 34.74 billion by 2026, from USD 20.72 billion in 2020, with a CAGR of 10.22%. The cost reduction strategies pursued by companies through subcontracting favor the growth of the market. This has drastically reduced the cost of medicines and made them affordable for a wider audience. The positive result of this trend can be seen in the higher focus of companies in the development and commercialization of medicines.

A promising portfolio of specific therapeutic agents will also contribute to market success in the coming years. These medications have minimal side effects and affect particular areas, allowing the patient to recover faster without reducing side effects. This positive perception of HPAPI, along with the expiration dates of highly successful drugs, which offer some generic drug manufacturers the opportunity to provide affordable medicines, will drive market growth. The rise of oncological research and the increase in cases of cancer, diabetes and other cardiovascular diseases have led to an urgent demand for specialized treatments, boosting the market of highly active pharmaceutical agents (HPAPI).

Report Scope:

Report Metric

Details

Market size available for years

2020-2026

Base year

2020

Forecast period

2020-2026

Segments covered

Type, Type of Manufacturer, Type of Synthesis, Therapeutic Application, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions covered

North America, APAC, Europe, Latin America and Middle East & Africa

Companies covered

Pfizer Inc., Novartis International AG, Merck & Co., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim, Sanofi, AbbVie, Eli Lilly and Company, AstraZeneca plc, Bristol-Myers Squibb, and GlaxoSmithKline plc.

Fastest Growing Market

Asia Pacific

Largest Market

North America

CAGR

10.22%

Click Here To Get Sample

 

Drivers and limitations of the High-Power API / HPAPI market:

Growth in this market is driven by factors such as the growing demand for oncological drugs, the increasing demand for antibody-drug conjugates, the rising concentration of the major pharmaceutical companies in HPAPI, advances in HPAPI manufacturing technologies and the growing focus on precision medicine.

On the other hand, it is expected that the need for significant investments, discrepancies in the systems of HPAPI bands, product uncertainties and the high risk of cross-contamination limit the growth of the market in the coming years. The need for appropriate process designs and the continuous development of industry standards and technologies must, to some extent, challenge the growth of the market.

This global market research report is segmented and sub-segmented on the following categories:

By Type

  • Innovative HPAPI
  • generic HPAPI

By Type of Manufacturer

  • Captive HPAPI manufacturer
  • HPAPI manufacturer merchant

By Type of Synthesis

  • Synthetic HPAPI market.
  • HPAPI biotechnology market

By Therapeutic Application

  • Oncology
  • Hormonal disorders
  • Glaucoma

By Region

  • North America
  • APAC
  • Europe
  • Latin America
  • Middle East & Africa

By the end of 2020, North America is expected to dominate the market, followed by Europe. However, Asia is expected to grow to the highest CAGR during the forecast period. Factors such as the growth of the geriatric population, the high prevalence of chronic diseases and lifestyle disorders, the increase in disposable income, the proliferation of lifestyle and geriatric diseases, the government's efforts to reform medical care and the introduction of generics, as well as the growth Market of manufacturers This region is responsible for the growth of the HPAPI market in Asia due to the low labor and manufacturing costs.

Key Market Players:

Some of the prominent players in this market are Pfizer Inc., Novartis International AG, Merck & Co., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim, Sanofi, AbbVie, Eli Lilly and Company, AstraZeneca plc, Bristol-Myers Squibb, and GlaxoSmithKline plc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Scope of the report                

                1.3 Study Assumptions                 

                1.4 Base Currency, Base Year and Forecast Periods                          

2. Research Methodology                                           

                2.1 Analysis Design                         

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Data Modelling      

                                2.2.4 Expert Validation  

                2.3 Study Timeline                          

3. Report Overview                                        

                3.1 Executive Summary                

                3.2 Key Inferencees                       

4. Market Dynamics                                       

                4.1 Impact Analysis                         

                                4.1.1 Drivers      

                                4.1.2 Restaints  

                                4.1.3 Opportunities        

                4.2 Regulatory Environment                       

                4.3 Technology Timeline & Recent Trends                            

5. Competitor Benchmarking Analysis                                    

                5.1 Key Player Benchmarking                     

                                5.1.1 Market share analysis        

                                5.1.2 Products/Service  

                                5.1.3 Regional Presence               

                5.2 Mergers & Acquistion Landscape                      

                5.3 Joint Ventures & Collaborations                        

6. Market Segmentation                                              

                6.1 High Potency APIs HPAPI Market, By Type                   

                                6.1.1 Innovative               

                                6.1.2 Generic    

                                6.1.3 Market Size Estimations & Forecasts (2021-2026)   

                                6.1.4 Y-o-Y Growth Rate Analysis             

                                6.1.5 Market Attractiveness Index          

                6.2 High Potency APIs HPAPI Market, By Synthesis                          

                                6.2.1 Synthetic 

                                6.2.2 Biotech     

                                6.2.3 moAB        

                                6.2.4 Vaccines   

                                6.2.5 Recombinant Proteins       

                                6.2.6 Market Size Estimations & Forecasts (2021-2026)   

                                6.2.7 Y-o-Y Growth Rate Analysis             

                                6.2.8 Market Attractiveness Index          

                6.3 High Potency APIs HPAPI Market, By Manufacturer                 

                                6.3.1 Captive     

                                6.3.2 Merchant

                                6.3.3 Market Size Estimations & Forecasts (2021-2026)   

                                6.3.4 Y-o-Y Growth Rate Analysis             

                                6.3.5 Market Attractiveness Index          

                6.4 High Potency APIs HPAPI Market, By Therapy                             

                                6.4.1 Oncology 

                                6.4.2 Glaucoma

                                6.4.3 Hormonal Imbalalnce         

                                6.4.4 Market Size Estimations & Forecasts (2021-2026)   

                                6.4.5 Y-o-Y Growth Rate Analysis             

                                6.4.6 Market Attractiveness Index          

7. Geographical Landscape                                         

                7.1 Global Identity Governance and Administration Market, by Region                  

                7.2 North America - Market Analysis (2021-2026)

                                7.2.1 By Country              

                                                7.2.1.1 USA

                                                7.2.1.2 Canada

                                7.2.2 By Type    

                                7.2.3 By Synthesis           

                                7.2.4 By Manufacturer  

                                7.2.5 By Therapy              

                7.3 Europe                         

                                7.3.1 By Country              

                                                7.3.1.1 UK

                                                7.3.1.2 France

                                                7.3.1.3 Germany

                                                7.3.1.4 Spain

                                                7.3.1.5 Italy

                                                7.3.1.6 Rest of Europe

                                7.3.2 By Type    

                                7.3.3 By Synthesis           

                                7.3.4 By Manufacturer  

                                7.3.5 By Therapy              

                7.4 Asia Pacific                  

                                7.4.1 By Country              

                                                7.4.1.1 China

                                                7.4.1.2 India

                                                7.4.1.3 Japan

                                                7.4.1.4 South Korea

                                                7.4.1.5 South East Asia

                                                7.4.1.6 Australia & NZ

                                                7.4.1.7 Rest of Asia-Pacific

                                7.4.2 By Type    

                                7.4.3 By Synthesis           

                                7.4.4 By Manufacturer  

                                7.4.5 By Therapy              

                7.5 Latin America                             

                                7.5.1 By Country              

                                                7.5.1.1 Brazil

                                                7.5.1.2 Argentina

                                                7.5.1.3 Mexico

                                                7.5.1.4 Rest of Latin America

                                7.5.2 By Type    

                                7.5.3 By Synthesis           

                                7.5.4 By Manufacturer  

                                7.5.5 By Therapy              

                7.6 Middle East and Africa                           

                                7.6.1 By Country              

                                                7.6.1.1 Middle East

                                                7.6.1.2 Africa

                                7.6.2 By Type    

                                7.6.3 By Synthesis           

                                7.6.4 By Manufacturer  

                                7.6.5 By Therapy              

8. Key Player Analysis                                    

                8.1 Pfizer Inc.                    

                                8.1.1 Business Description           

                                8.1.2 Products/Service  

                                8.1.3 Financials 

                                8.1.4 SWOT Analysis       

                                8.1.5 Recent Developments       

                                8.1.6 Analyst Overview 

                8.2 Novartic International AG                    

                8.3 Merck & Co.                               

                8.4 Teva Pharmaceutical Industries Ltd.                

                8.5 Mylan Inc.                   

                8.6 Boehringer Ingelheim                            

                8.7 Sanofi                           

                8.8 AbbVie                         

                8.9 Eli Lily and Company               

                8.10 AstraZeneca                            

9. Market Outlook & Investment Opportunities                                

Appendix                                           

                List of Tables                     

                List of Figures                   

  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

  • Segment-level analysis in terms of by type, by manufacturer, along with market size forecasts and estimations to detect key areas of industry growth in detail

  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development

  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions

  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

  1. Global High Potency APIs HPAPI Market By Region, From 2021-2026 ( USD Billion )
  2. Global High Potency APIs HPAPI Market By Type, From 2021-2026 ( USD Billion )
  3. Global Innovative Market By Region, From 2021-2026 ( USD Billion )
  4. Global Generic Market By Region, From 2021-2026 ( USD Billion )
  5. Global High Potency APIs HPAPI Market By Synthesis, From 2021-2026 ( USD Billion )
  6. Global Synthetic Market By Region, From 2021-2026 ( USD Billion )
  7. Global Biotech Market By Region, From 2021-2026 ( USD Billion )
  8. Global moAB Market By Region, From 2021-2026 ( USD Billion )
  9. Global Vaccines Market By Region, From 2021-2026 ( USD Billion )
  10. Global Recombinant Proteins Market By Region, From 2021-2026 ( USD Billion )
  11. Global High Potency APIs HPAPI Market By Manufacturer, From 2021-2026 ( USD Billion )
  12. Global Captive Market By Region, From 2021-2026 ( USD Billion ) 
  13. Global Merchant Market By Region, From 2021-2026 ( USD Billion )
  14. Global High Potency APIs HPAPI Market By Therapy, From 2021-2026 ( USD Billion )
  15. Global Oncology Market By Region, From 2021-2026 ( USD Billion )
  16. Global Glaucoma Market By Region, From 2021-2026 ( USD Billion )
  17. Global Hormonal Imbalance Market By Region, From 2021-2026 ( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample